Most cited article - PubMed ID 37357529
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
Histone deacetylases (HDACs) are frequently deregulated in cancer, and several HDAC inhibitors (HDACi) have gained approval for treating peripheral T cell lymphomas. Here, we investigated the effects of pharmacological or genetic HDAC inhibition on NPM::ALK positive anaplastic large cell lymphoma (ALCL) development to assess the potential use of HDACi for the treatment of this disease. Short-term systemic pharmacological inhibition of HDACs using the HDACi Entinostat in a premalignant ALCL mouse model postponed or even abolished lymphoma development, despite high expression of the NPM::ALK fusion oncogene. To further disentangle the effects of systemic HDAC inhibition from thymocyte intrinsic effects, conditional genetic deletions of HDAC1 and HDAC2 enzymes were employed. In sharp contrast, T cell-specific deletion of Hdac1 or Hdac2 in the ALCL mouse model significantly accelerated NPM::ALK-driven lymphomagenesis, with Hdac1 loss having a more pronounced effect. Integration of gene expression and chromatin accessibility data revealed that Hdac1 deletion selectively perturbed cell type-specific transcriptional programs, crucial for T cell differentiation and signaling. Moreover, multiple oncogenic signaling pathways, including PDGFRB signaling, were highly upregulated. Our findings underscore the tumor-suppressive function of HDAC1 and HDAC2 in T cells during ALCL development. Nevertheless, systemic pharmacological inhibition of HDACs could still potentially improve current therapeutic outcomes.
- MeSH
- Anaplastic Lymphoma Kinase * metabolism genetics MeSH
- Lymphoma, Large-Cell, Anaplastic * drug therapy pathology genetics metabolism MeSH
- Benzamides pharmacology MeSH
- Histone Deacetylase 1 * genetics antagonists & inhibitors physiology metabolism MeSH
- Histone Deacetylase 2 genetics MeSH
- Histone Deacetylase Inhibitors * pharmacology therapeutic use MeSH
- Humans MeSH
- Mice MeSH
- Pyridines pharmacology MeSH
- Genes, Tumor Suppressor * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Alk protein, mouse MeSH Browser
- Anaplastic Lymphoma Kinase * MeSH
- Benzamides MeSH
- entinostat MeSH Browser
- Hdac1 protein, mouse MeSH Browser
- Histone Deacetylase 1 * MeSH
- Histone Deacetylase 2 MeSH
- Histone Deacetylase Inhibitors * MeSH
- Pyridines MeSH